secwatch.observer — SEC 8-K summary
======================================

Issuer:     Azenta, Inc. (AZTA)
CIK:        0000933974
Form:       8-K
Filed at:   2026-04-07T23:59:59+00:00
Accession:  0001437749-26-011542
Event type: leadership
Sentiment:  positive
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Azenta appoints Trey Martin as Multiomics President; Ginger Zhou steps down
---------------------------------------------------------------------------

- Trey Martin appointed President of Multiomics effective April 6, 2026; reports to CEO John Marotta.
- Martin most recently served as CEO of Maravai LifeSciences (MRVI) and previously led IDT under Danaher (DHR).
- Ginger Zhou stepped down as President; she will remain as advisor through November 2026 under a consulting agreement with $103,500 initial fee.
- Executive officers Lawrence Lin, Ephraim Starr, and Olga Pirogova received amended offer letters clarifying severance and change-in-control terms.
- Azenta aims to accelerate Multiomics long-range plan focusing on global synthesis scale, operational excellence, and profitable growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/933974/000143774926011542/0001437749-26-011542-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/933974/000143774926011542/azta20260407_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-011542

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer